First Personal Financial Services Revance Therapeutics, Inc. Transaction History

First Personal Financial Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$27.45 - $33.35 $18,446 - $22,411	-672 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$29.15 - $37.4 $13,409 - $17,204	-460 Reduced 40.64%	672 $21,000
Q4 2017 Jan 25, 2018	BUY	$24.55 - $36.3 $7,954 - $11,761	324 Added 40.1%	1,132 $40,000
Q3 2017 Nov 01, 2017	BUY	$22.55 - $28.1 $18,220 - $22,704	808	808 $22,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.